HFS
CLB icon

Hantz Financial Services’s Core Laboratories CLB Stock Holding History

Hantz Financial Services’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35K Sell
3,041
-14
-0.5% -$200 ﹤0.01% 1778
2026
Q1 		$51K Sell
3,055
-122
-4% -$2.18K ﹤0.01% 1550
2025
Q4 		$51K Buy
3,177
+1,763
+125% +$26.2K ﹤0.01% 1421
2025
Q3 		$17K Buy
1,414
+1,088
+334% +$12.8K ﹤0.01% 1613
2025
Q2 		$4K Buy
+326
New +$3.87K ﹤0.01% 1793

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Hantz Financial Services's CLB Position: Q2 2026 in Review

Hantz Financial Services reduced its Core Laboratories (CLB) stake by 0.46% in Q2 2026, selling an estimated $200 and leaving 3,041 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

Hantz Financial Services first reported a position in CLB in Q2 2025 and has held it in 5 quarters since. The position peaked at $51K in Q1 2026. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Hantz Financial Services held 3,041 shares of Core Laboratories worth $35K as of Q2 2026.
  • Hantz Financial Services sold 14 Core Laboratories shares in Q2 2026, an estimated $200.
  • Core Laboratories made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1778 holding.
  • Hantz Financial Services first reported a position in Core Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Hantz Financial Services's Core Laboratories position peaked at $51K in Q1 2026.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.